Digital Pathology Statistics By Market Size, Adoption and Facts

Introduction

Digital Pathology Statistics: The advancements in digital pathology are transforming the field of pathology, replacing the microscope-based diagnostics practice with a digital, image-based environment. It improves the accuracy and efficiency of analysis while increasing accessibility to pathological results. By 2024, the digital pathology market was globally valued at an estimated worth of USD 1.07 billion, indicating the growing relevance of this field in modern healthcare.

This article discusses the important Digital pathology statistics market in 2025 market size, projections of growth, regional insights,-some product segmentation, and the factors propelling this dynamic industry.

Editor’s Choice

• By 2024, the global digital pathology market is expected to reach USD 1.19 billion, growing from USD 1.10 billion in 2023.
• Projections indicate that the market will reach USD 2.58 billion by 2034, driven by advancements in artificial intelligence, improved diagnostics, and demand for remote pathology solutions.
• North America holds the largest market share at 41%, followed by Europe at 27%, Asia Pacific at 21%, Latin America at 8%, and the Middle East & Africa at 3%.
• In Latin America, the digital pathology market was valued at USD 50 million in 2020 and is expected to reach USD 81 million by 2025, with a CAGR of 10.1%.
• Veterinary pathology applications make up 39% of the market, while human pathology accounts for 28%.
• Hospitals are the largest end-users at 38%, followed by diagnostic labs at 29%, biotech and pharmaceutical companies at 21%, and academic research institutes at 12%.
• The adoption of digital pathology has increased significantly in the past five years, rising from 15% to 37%.
• By 2023, 70% of organizations in the life sciences sector had adopted digital pathology, with an additional 53% planning adoption by the end of the year.
• 81% of respondents reported having access to digital slide scanners, with 62.9% preferring Aperio/Leica.
• 40.6% of organizations reported no support for digital pathology resources, while 46.9% had no budget allocation for digital pathology or machine learning.
• Roche has integrated AI into its Digital Pathology Open Environment, and Deciphex raised EUR 31 million in early 2025 to enhance AI-supported diagnostics.

Digital Pathology Market Size By Market.us

• The digital pathology market size is expected to reach USD 2,185.8 million by 2032, growing from USD 918.5 million in 2022.
• The market is projected to grow at a CAGR of 9.3% from 2023 to 2032.
• North America held the largest share, accounting for 42% of global revenue in 2022.

Digital Pathology Market Value In Latin America

(Reference: statista.com)

• Digital pathology statistics show that digital pathology is on a fast growth trajectory in Latin America, with a market valuation of about USD 50 million in 2020 and a projection of reaching around USD 81 million by 2025.
• Such values translate into a compound annual growth rate (CAGR) of about 10.1%.
• It is primarily driven by the growing digital technology adoption in pharmaceutical pathology labs.
• Instead of physical microscopes, digital equipment is used for more efficient medical sample analysis.
• Such a high level of accuracy speeds up diagnosis, making healthcare systems within the country more advanced.

Digital Pathology Market Size By Precedence Research

(Reference: precedenceresearch.com)

• At first glance, digital pathology markets sounded awesome. The global digital pathology market has been consistent and has kept its steady pace over the years.
• Digital pathology statistics state that as of 2023, the value of this market was at USD 1.10 billion, and by 2024, it had increased to USD 1.19 billion.
• Further projections of this rising pattern are set for USD 1.28 billion in 2025 and USD 1.39 billion in 2026.
• The volume of this market size is anticipated at USD 1.50 billion by 2027, USD 1.62 billion in 2028, and USD 1.75 billion next year in 2029.
• Continuing its prosperity path, the market is equally projected at USD 1.89 billion in 2030, USD 2.04 billion in 2031, and USD 2.21 billion in 2032.
• In 2033, the value is estimated to reach USD 2.39 billion and is projected to rise to USD 2.58 billion in 2034. This continual elongation that is developing digital pathology will enjoy integrated futures that will continue to rise into the healthcare system.
• There are now technological advancements, better diagnostic accuracy, and a growing increase in demand for remote pathology solutions, which describes the reasons why this market is expanding globally.

Digital Pathology Market By Region

(Reference: precedenceresearch.com)

• Digital pathology statistics depict that the digital pathology market is on quite a regional divide, with North America leading the charge at 41% of the total market share.
• This is credited to its advanced healthcare system, high investments in medical technology, and thus widespread acceptance of digital pathology solutions.
• In its wake follows Europe at 27%, having some stubborn research and healthcare infrastructure to lean on.
• The Asia Pacific holds a 21% share, with the propelling factors being fast-paced technological advancements in healthcare requirements.
• Latin America, with an 8% share, is showing a steady increase as digital solutions are being increasingly accepted in medical diagnostics.
• The Middle East & Africa holds the smallest share, at 3%, but sows the seeds for gradual growth with improvements in healthcare access and the embrace of digital technology.

Share Of Digital Pathology By Type

(Reference: statista.com)

• Digital pathology finds its applications in both the veterinary and human sphere but the adoption varies occupation-wise.
• Veterinary pathology forms the lion’s share of this market, with a 39% footprint.
• This means so much of digital pathology applications are directed towards diagnosing diseases in animals.
• The remaining human pathologies stand for 28%. It shows that digital pathology is quite widely used for diagnosing diseases in humans as well, but perhaps a notch less than in humans.
• This might differ based on reasons such as the cost of implementation of digital pathology, regulatory bottlenecks, and generally faster adoption of digital tools by animal health.

Digital Pathology End Use

(Reference: precedenceresearch.com)

• Whether hospitals or private laboratories, relevant bodies aptly hold the most percentages of digital pathology usage.
• Digital pathology statistics indicate that 38% of hospitals obtained the highest usefulness percentage for a reason. They house a heavy load of medical tests, which they supplement with high speed and accuracy.
• The other big users are the diagnostic labs, with 29%, which also do the same but help the digitalization in the analysis of patient samples.
• Biotech and pharmaceutical companies all accrue to 21%, using digital pathology in drug development and research.
• Last but not least is the academic and research institutes with 12%. The digital imaging technology is used to understand diseases and develop new treatments.

Adoption And Usage

• Digital pathology statistics show that digital pathology adoption has increased from about 15% five years ago to 37% as of 2023.
• Among life sciences organizations, 70% have instituted digital pathology by 2023, while a mere 53% of them plan to implement it before the end of the year.
• Adoption rates are high; an overwhelming 81% of them said they have a digital slide scanner. More than half of the users (62.9%) prefer using Aperio/Leica’s slide scanner, which happens to be the most widely used. Institutional support is a huge boost to adoption, with 50% of respondents supported by their institutions in purchasing and operating digital slide scanners.
• However, 40.6% admitted that they had no support for digital pathology or machine learning resources, whereas only 15.6% maintained service contracts for their equipment. Allocations for budgets on digital pathology vary widely.
• Digital pathology statistics state that almost 46.9% of the respondents did not allocate any budget to digital pathology or machine learning, while 28.13% allocated less than 5% budget to either of the two.
• Interestingly, however, around 9.4% were said to be unencumbered about their budget allocation in the institution for this area.
• Awareness of machine learning applications in universities is relatively high, with 76% acknowledging through self-declaration that other departments use this technology.
• However, the same proportion, 76%, were aware of no multi-university or industry collaborative activities on digital pathology among partners.
• Managing digital pathology infrastructure is still problematic. Only 25% have a dedicated individual overseeing these systems, while 53.1% think that centralizing slide scanning at a single site would be beneficial.
• On the contrary, 41% indicated that their facility lacks support for digital pathology and machine learning resources. Again, storage and data management remain murky areas.
• About 37% of respondents do not know the average file size of scanned images, and 50% have no idea about the storage space required to manage digital pathology data.

Emerging Trends

• The interface of Artificial Intelligence and machine learning with digital pathology is changing the landscape of diagnostics with enhanced accuracy and efficiency.
• Most advanced AI algorithms can analyze complex image data with relative ease to fasten and improve tumor diagnosis by pathologists such as that of cancer with precision.
• This technological development gives a dimension of critical analysis that is impossible by conventional means.
• Imaging technology has scored important advancements that further improve digital pathology through good-quality resolution tissue slide scanning. This transition from handling physical slides to digital interaction permits efficient analysis by pathologists.
• Advanced imaging provides detailed and clear images, helping in making accurate diagnostics. The advent of digital pathology has changed the way medical professionals collaborate.
• Pathologists can now share digital slides with their respective colleagues all over the world, a situation most favorable for places with limited access to specialized expertise. These enhanced connections promote collaborative diagnosis and enhance consultation, ultimately benefitting patient welfare.
• Optimizing laboratory workflow is the other major area where digital pathology is beneficial. Optimized workflows allow laboratories to significantly reduce patient turnaround time for results, an important thing to have in a fast-paced medical constituency.
• Such speedy tests mean quick patient care, and also increased patient benefits by reducing costs and logistics of handling slides conventionally. This trend has increased the acceptance of digital pathology, with recent regulatory steps being taken, including the initiation of dedicated billing codes for digital pathology services.
• These changes make for easier adaptation of digital pathology within the healthcare system by ensuring proper recognition and reimbursement of the offered services.
• Continuing support from a regulatory perspective is crucial to expanding the process of acceptance of digital pathology in mainstream healthcare.

Key Players Statistics

• Digital pathology statistics state that Olympus Corporation has a strong standing in the field of digital pathology, where it relies on optical and digital precision technology. The company has launched the Evident SLIDEVIEW™ DX VS-M1 whole-slide imaging system, which enables high-speed slide scanning at high quality, thus facilitating an efficient method of diagnostic pathology. The innovation creates a microscope-like image using Olympus’s optical and digital imaging prowess to enable pathologists to make timely and precise decisions.
• Olympus has now teamed up with Grundium to actively integrate high-end X Line objectives into Grundium’s Ocus® portable microscope scanners. This will provide even more flexibility, accuracy, and speed for distance pathology consultations, allowing pathologists to analyze samples from much farther away with greater efficiency.
• Hamamatsu Photonics, Inc. is well-known for the NanoZoomer series of whole-slide scanners, which convert classical glass slides into high-resolution digital images. These scanners are of real importance for pathology laboratories around the world, providing greater detail and accuracy for diagnostic analyses.
• The company has partnered with Siemens Healthineers to have the NanoZoomer scanners interfaced into a broader scope of medical imaging systems, thus serving as a bridge from pathology to radiology to the benefit of care workflows and the efficiency of healthcare systems. Hamamatsu will maintain its focus on photonics engineering and digital imaging, which positions it squarely in the lead in the digital pathology sector.
• Through the promotion of 3DHISTECH’s novel pathology instruments and software, Thermo Fisher Scientific Inc. contributes to enhancing digital pathology. The company has digital tools like the Pannoramic™ Desk II and Pannoramic 1000 slide scanners for high-throughput slide scanning and image management of pathology.
• These advanced scanning systems enhance modern laboratory workflow efficiencies and diagnostic accuracy. The ever-increasing demand for telepathology and remote diagnostics is the leading growth driver for the digital pathology market, which is anticipated to reach USD 2.08 billion by 2032. Thermo Fisher stays ahead of this market transition, assisting laboratories to make speedier and correct diagnoses.
• Digital pathology statistics reveal that 3DHISTECH Ltd. concentrates on high-resolution slide scanners and complete digital pathology systems. Their PANNORAMIC series runs up to 200,000 slides a year, supplying both research and clinical laboratories. Integrative solutions, like CaseViewer and QuantCenter software for image analysis and case management, help streamline workflows in pathology laboratories.
• One of its more interesting recent releases is the improved P480 2nd Gen, an enhanced version that further pushes the digitization envelope in pathology laboratories. 3DHISTECH is vital to the advancement of cancer diagnostics and supports a global network of laboratories with its state-of-the-art digital pathology solutions.

Technological Advancements And Investments

• Digital pathology statistics state that technological innovations seem to drive the expansion of the digital pathology market. The integration of artificial intelligence (AI) and machine learning into diagnostic processes has provided enhanced image analysis and pattern recognition.
• For instance, in September 2024, Roche’s Digital Pathology Open Environment was augmented with over 20 AI algorithms from eight partners.
• These AI algorithms do further enhancement of cancer diagnostics. This initiative helps the clinician in precision medicine, which translates into better patient outcomes with targeted therapy.
• In January 2025, Deciphex, an Irish med-tech company working on AI-assisted diagnostics, raised €31 million to fight global pathologist shortages through speed and accuracy of disease identification.
• Investments like this highlight the recognition of digital pathology as being a possible tool to revolutionize diagnostic medicine.

Conclusion

According to Digita pathology statistics, We have seen high growth in the digital pathology market owing to advancing technologies, the increasing incidence of chronic diseases, and the greater need for rapid diagnostic approaches. The attractiveness of digital pathology is being recognized by healthcare stakeholders as a means of improving accuracy and efficiency in diagnosis due to these forecasts for growth.

With an influx of investments and innovations, digital pathology can be heralded as the game player in the field of medical diagnostics in the years to come.

Barry Elad

Barry Elad is a tech enthusiast who loves diving deep into various technology topics. He gathers important statistics and facts to help others understand the tech world better. With a keen interest in software, Barry writes about its benefits and how it can improve our daily lives. In his spare time, he enjoys experimenting with healthy recipes, practicing yoga, meditating, or taking nature walks with his child. Barry’s goal is to make complex tech information easy and accessible for everyone.

More Posts By Barry Elad

Monday.com Statistics and Facts (2025)

Netflix Statistics and Facts (2025)

Twitter (X) Statistics And Facts [2025]

Snapchat Statistics By Revenue, User And Facts

ServiceNow Statistics By Market, Revenue, Employees And Fact

Gmail Statistics By Users, Usage and Facts

Canva Statistics By Revenue, Market Share, Users, Downloads and Facts

Digital Pathology Statistics By Market Size, Adoption and Facts

Supercapacitors Statistics By Regional Market And Usage

Brother Statistics By Revenue, Region And Employees